Press Releases Sanofi BOERSE MUENCHEN

Equities

SNW

FR0000120578

Market Closed - BOERSE MUENCHEN Other stock markets 03:43:54 2024-07-16 pm EDT			5-day change	1st Jan Change
91.8 ^EUR	-0.89%		-0.12%	+3.15%

Jul. 16	SANOFI : JP Morgan remains Neutral	ZD
Jul. 12	Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market	RE

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sanofi ships U.S. influenza vaccines for the 2024/25 season	Jul. 10	PR
Sanofi - Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD	Jul. 04	AQ
Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD	Jul. 03	GL
Sanofi - Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM	Jun. 27	AQ
Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM	Jun. 26	GL
Press Release: Availability of the Q2 2024 Aide-mémoire	Jun. 25	GL
Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee	Jun. 21	GL
List of Companies That Allegedly Left Nigeria Under Tinubu's Presidency Is Not Accurate	Jun. 21	AQ
Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran	Jun. 21	GL
Press Release: Sanofi and Biovac spearhead polio vaccine manufacturing capabilities in Africa	Jun. 20	GL
INNATE PHARMA SHARES UPDATED RESULTS FROM THE SANOFI DEVELOPED BLOOD CANCER PHASE SAR443579/IPH6101 TRIAL	Jun. 18	AQ
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Mai 2024	Jun. 12	PU
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development (CRDL,JAZZ, NVO, AZN, SNY)	Jun. 11	AQ
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development	Jun. 11	AQ
I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer	Jun. 07	AQ
Deerfield Management Welcomes Frank Nestle, MD, FMedSci, as Partner and Chief Executive Officer of Therapeutic Discovery and Development	Jun. 06	AQ
SANOFI : L’AMMC vise le prospectus relatif à l’augmentation de capital du groupe « SANOFI » réservée aux salariés du groupe	Jun. 04	PU
Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3	Jun. 03	GL
Sanofi - Dupixent recommended for EU approval by the CHMP to treat patients with COPD	Jun. 03	AQ
Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan	May. 31	GL